SOLARA ACTIVE PHARMA SCIENCES Ltd.

BSE: 541540 | NSE: SOLARA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE624Z01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

SOLARA ACTIVE SOLARA ACTIVE PHARMA SCIENCES Ltd. | BSE 555.60 31.00 (5.91%) | NSE 556.00 32.25 (6.16%) | Trade | Add

BSE Live

Dec 03, 14:16

555.60 31.00 (5.91%)

Volume

AVERAGE VOLUME

5-Day

3,837

10-Day

19,210

30-Day

10,226

61,241

Prev. Close

524.60
Open Price

525.05

Bid Price (Qty.)
554.60 (7)
Offer Price (Qty.)
556.05 (17)

NSE Live

Dec 03, 14:16

556.00 32.25 (6.16%)

Volume

AVERAGE VOLUME

5-Day

81,733

10-Day

98,871

30-Day

96,256

1,302,540

Prev. Close

523.75
Open Price

527.95

Bid Price (Qty.)
555.00 (9)
Offer Price (Qty.)
555.65 (1)

Financials

Print/Copy to Excel : Go

Balance Sheet of SOLARA ACTIVE PHARMA SCIENCES (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	40.25	36.00	36.00	36.00	35.92
Total Share Capital	40.25	36.00	36.00	36.00	35.92
Reserves and Surplus	1,055.96	899.77	1,466.08	1,491.05	1,556.86
Total Reserves and Surplus	1,055.96	899.77	1,466.08	1,491.05	1,556.86
Total Shareholders Funds	1,096.21	937.42	1,503.13	1,527.05	1,592.78
NON-CURRENT LIABILITIES
Long Term Borrowings	113.86	105.83	235.10	283.04	154.83
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.00
Other Long Term Liabilities	67.11	55.62	49.93	61.83	65.89
Long Term Provisions	9.85	10.08	10.67	9.49	11.36
Total Non-Current Liabilities	190.82	171.53	295.70	354.36	232.08
CURRENT LIABILITIES
Short Term Borrowings	662.20	893.55	766.05	741.53	360.88
Trade Payables	242.59	307.70	300.69	280.77	305.63
Other Current Liabilities	31.05	34.43	27.30	42.52	116.97
Short Term Provisions	2.23	1.97	2.08	3.44	1.83
Total Current Liabilities	938.07	1,237.65	1,096.12	1,068.26	785.31
Total Capital And Liabilities	2,225.10	2,346.60	2,894.95	2,949.67	2,610.17
ASSETS
NON-CURRENT ASSETS
Tangible Assets	789.82	851.24	913.97	892.16	904.61
Intangible Assets	394.70	407.46	419.25	432.84	444.88
Capital Work-In-Progress	280.05	256.37	238.47	238.65	87.72
Other Assets	2.28	2.39	8.79	9.15	9.52
Fixed Assets	1,466.85	1,517.46	1,580.48	1,572.80	1,446.73
Non-Current Investments	1.70	14.25	16.05	18.13	18.13
Deferred Tax Assets [Net]	0.00	0.00	78.54	55.14	25.55
Long Term Loans And Advances	0.00	0.00	0.00	1.59	1.65
Other Non-Current Assets	27.95	24.24	29.01	62.14	60.12
Total Non-Current Assets	1,496.50	1,555.95	1,704.08	1,709.80	1,552.18
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	317.90	359.70	558.09	575.55	294.97
Trade Receivables	326.57	351.22	539.65	489.67	483.81
Cash And Cash Equivalents	3.97	8.48	8.71	47.14	198.38
Short Term Loans And Advances	0.02	0.34	32.62	51.58	1.65
OtherCurrentAssets	80.14	70.91	51.80	75.93	79.18
Total Current Assets	728.60	790.65	1,190.87	1,239.87	1,057.99
Total Assets	2,225.10	2,346.60	2,894.95	2,949.67	2,610.17
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	57.61	42.63	38.00	66.88	104.50
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	0.00
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	656.23	713.32	713.32	676.06	668.81
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	1,170.55	1,164.22	1,164.22	940.44	914.82
BONUS DETAILS
Bonus Equity Share Capital	9.07	9.07	9.07	9.07	9.07
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	1.70	14.25	16.05	17.71	18.13
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--